Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding

Author： Matsubara Y Katoh S Taniguchi H Oka M Kadota J Kohno S

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.28, Iss.2, 2000-03, pp. : 78-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The inhibition of neutrophil–endothelial cell adhesion by hyaluronan independent of CD44

By Alam C. A. S. Seed M. P.

Inflammopharmacology, Vol. 12, Iss. 5-6, 2004-12 ,pp. : 535-550

VSP

Access to resources Recommend Favorite

CD44 and its Role in Inflammation and Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 208-220

Bentham Science Publishers

Access to resources Recommend Favorite

Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma

By Journo-Gershfeld Gal Kapp Dana Shamay Yosi Kopeček Jindřich David Ayelet

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1121-1133

Springer Publishing Company

Access to resources Recommend Favorite

CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 572-585

Bentham Science Publishers

Access to resources Recommend Favorite

The Urokinase Receptor and its Structural Homologue C4.4A in Human Cancer: Expression, Prognosis and Pharmacological Inhibition

Current Medicinal Chemistry, Vol. 15, Iss. 25, 2008-10 ,pp. : 2559-2573

Bentham Science Publishers

Access to resources Recommend Favorite